©The Author(s) 2025.
World J Clin Cases. Nov 26, 2025; 13(33): 110641
Published online Nov 26, 2025. doi: 10.12998/wjcc.v13.i33.110641
Published online Nov 26, 2025. doi: 10.12998/wjcc.v13.i33.110641
Table 4 Primary and secondary outcomes odds ratio after multivariate regression
| Outcomes | Odds ratio | P value | 95%CI |
| Interstitial lung diseases | 2.203 | < 0.001 | 1.843-2.219 |
| Usual interstitial pneumonia/pulmonary fibrosis | 3.200 | < 0.001 | 2.800-3.700 |
| Non-specific interstitial pneumonia | 3.500 | < 0.001 | 2.900-4.100 |
| Eosinophilic lung disease | 0.232 | < 0.001 | 0.112-0.415 |
| Respiratory bronchiolitis interstitial lung disease | 1.636 | 0.002 | 0.531-5.036 |
| Cryptogenic organizing pneumonia | 96.040 | 0.06 | 0.860-1072 |
| Acute interstitial pneumonitis | 2.201 | < 0.001 | 0.764-6.335 |
| Acute respiratory distress syndrome | 1.116 | 0.260 | 0.921-1.353 |
| Pneumothorax | 1.848 | < 0.001 | 1.465-2.332 |
| Pleural effusion | 1.028 | 0.49 | 0.959-1.101 |
| Pulmonary arterial hypertension | 1.397 | < 0.001 | 1.331-1.467 |
- Citation: Sutton J, Khattar G, Saliba F, Mourad O, Aoun L, Jdaidani J, Qandil H, Kaspar C, Abu-Baker S, Almardini S, Haddadin F, Bou Sanayeh E, Slobodnick A. Impact of type 2 diabetes mellitus on interstitial lung disease risk in rheumatoid arthritis. World J Clin Cases 2025; 13(33): 110641
- URL: https://www.wjgnet.com/2307-8960/full/v13/i33/110641.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v13.i33.110641